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Thirteen dogs affected with X-linked Duchenne's muscular dys-
trophy and 11 female carrier dogs were studied by electrocardi-
ography (ECG) and echocardiography. Twelve of the affected dogs 
were studied as immature animals and followed at 1 to 6 month 
intervals until they were 7 to 46 months of age. Compared with 
control dogs, affected dogs had significantly increased (p < 0.02) QIR 
ratios in ECG leads II, III, aVF, CV6LL (V2) and CV6LU (V4). 
Carrier dogs had significantly increased (p < 0.02) QIR ratios in 
leads V 2 and V 4' The QIR ratio increased in three of six dogs followed 
up from age 6 months to >2 years. The PR intervals were signifi-
Duchenne's muscular dystrophy is a common inherited 
neuromuscular disorder in humans. The disease affects 
approximately 1 in 3,500 male births with an X-linked 
inheritance (1) and is characterized by continuing muscular 
necrosis and regeneration with eventual replacement of 
muscle with fibrosis and fatty infiltration (2). The gene that, 
when defective, causes Duchenne's muscular dystrophy has 
recently been identified (3,4). Its product, dystrophin, is a 
putative cytoskeletal protein (4) that is localized on immu-
no staining to the cytoplasmic aspect of the plasma mem-
brane (5,6) and has been reported (7,8) to be absent or 
defective in patients with Duchenne's muscular dystrophy. 
The majority of patients with Duchenne's muscular dystro-
phy lack immunohistochemically demonstrable dystrophin 
(9). 
The severity of the skeletal muscle disease in Duchenne's 
muscular dystrophy has focused studies on this tissue; 
however, the presence of myocardial disease also has 
been widely recognized (10-18). Duchenne's cardiomyopa-
thy is characterized by progressive epimyocardial fibrosis 
primarily in the posterobasal left ventricular free wall 
(14,19,20). Clinical signs of congestive heart failure are 
delayed until shortly before death (21-23). The electro-
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cantly shorter (p < 0.02) in affected dogs. Ventricular arrhythmias 
were identified in four of six mature affected dogs. 
Two-dimensional echocardiography revealed distinctive hyper-
echoic lesions in 12 of the 13 affected dogs and in 6 of the 11 carrier 
dogs. Hyperechoic lesions corresponded to calcified myocardium 
and surrounding dense connective tissue. This study establishes 
the dog affected with Duchenne's muscular dystrophy as an 
animal model of Duchenne's cardiomyopathy and demonstrates 
that the heart in carrier dogs is affected by the dystrophic process. 
(J Am Coil CardioI1991;17:812-20) 
cardiogram (ECG) is distinctly abnormal in virtually all 
patients with Duchenne's muscular dystrophy (24-33), 
Echocardiography reveals diastolic function abnormalities 
and also reveals systolic failure in some older patients 
(10,11,14,21,23,34-43). 
The mouse (4,7) and dog (44-48) with muscular dystro-
phy, both of which lack dystrophin in muscle tissue (9,44), 
are models for Duchenne's muscular dystrophy in humans. 
The phenotypic expression of the disease in the dog is more 
similar to that in humans than is the muscular dystrophy in 
the mouse (46,47,49). Recently, the pathology of Du-
chenne's cardiomyopathy was described in the dog (50), 
with myocardial fibrosis being a prominent feature. Fibrosis 
was preceded by myocyte necrosis and mineralization. 
In skeletal muscle of dogs that carry the Duchenne' s 
muscular dystrophy gene, dystrophin is initially expressed in 
a mosaic pattern. However, as carriers mature, this hetero-
geneity is lost. In contrast, mosaicism for dystrophin appar-
ently persists in the heart for the life of the animal, with 
approximately 50% of cardiac myocytes expressing dystro-
ph in and 50% lacking dystrophin (51). 
This study presents evidence that shows the similarities 
in the cardiomyopathy associated with Duchenne's mus-
cular dystrophy in humans and dogs. Some human female 
carriers of the muscular dystrophy gene are known to have 
abnormal EeGs; however, detailed studies of the heart that 
adequately describe the cardiac involvement have not been 
done. Electrocardiographic and echocardiographic abnor-
malities presented here prove that female dogs carrying the 
muscular dystrophy trait have cardiac disease and that dogs 
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affected with muscular dystrophy are important models for 
the study of Duchenne' s cardiomyopathy. 
Methods 
Study groups. Thirteen golden retriever or golden 
retriever-cross dogs (6 female and 7 male) affected with 
X-linked Duchenne's muscular dystrophy were studied; 11 
female carrier dogs also were studied. All dogs were descen-
dants of a single affected male dog (45) and were part of a 
muscular dystrophy breeding colony. Affected male and 
female and obligate carrier female dogs resulted from mat-
ings between affected male and carrier female dogs. One 
affected dog was studied initially as an adult at the age of 6 
years. The remaining 12 affected dogs were studied as 
immature animals (2 to 11 months) and followed up at 1 to 6 
month intervals until they were 7 to 46 months of age. Three 
dogs were studied to the age of 7 months, 4 to the age of 12 
to 16 months and 5 to >24 months of age. The 11 carrier 
female dogs were studied once as adults (21 to 48 months of 
age). 
Dogs were studied by physical examination, ECG, echo-
cardiography and radiography. Age and breed specific crite-
ria are not available for the evaluation of Q waves in dogs. 
Therefore, the ECGs of affected dogs examined at d years 
of age (age range 2 to 6 years) and of the carrier dogs were 
compared with those of 20 control golden retriever dogs (12 
female and 8 male, age range 2 to 7 years). Control dogs had 
a normal physical examination, thoracic radiograph, and 
echocardiogram. Rhythm disturbances and ventricular or 
supraventricular premature activities also were assessed. 
Electrocardiography. Leads I, II, III, aVR, aVL, aVF, 
CV5RL, CV6LL and CV6LU were recorded on all dogs (52) 
(Hewlett-Packard model 4700A electrocardiograph). The 
precordial lead CV 5RL was positioned over the fifth inter-
costal space on the right side of the thorax near the sternum 
and corresponds closely to VI used in humans. The precor-
dial leads CV 6LL and CV 6LU were positioned over the sixth 
intercostal space on the left side of the thorax just above the 
sternum (LL) and at the costochondral junction (LU). These 
precordial leads correspond closely to leads V 2 and V 4 used 
in humans, respectively. The P wave amplitude and dura-
tion, PR and QT intervals, QRS amplitude and duration and 
heart rate were determined in lead II. The RlS ratio in lead 
CV 5RL and the mean electrical axis in the frontal plane were 
determined. The Q and R wave amplitudes were determined 
and the Q/R ratio was calculated in leads I, II, III, aVL, 
aVF, CV6LL and CV6LU. 
Echocardiography. Two-dimensional and two-dimen-
sional-derived M-mode echocardiography were performed 
on all dogs (Hewlett-Packard model 77020A Ultrasound 
System). Two-dimensional echocardiograms were evaluated 
for the uniformity of myocardial echogenicity. The following 
measurements were determined from the M-mode echocar-
diograms for all dogs 2:2 years of age: ventricular septum 
and left ventricular free wall thickness at end-diastole and 
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Table 1. Electrocardiographic Variables in Normal Dogs and 
Dogs Affected With or Carriers of Duchenne's Muscular 
Dystrophy 
Minimum Median Maximum 
Q/R I 
Normal dogs 0 0.44 2.00 
Carrier dogs 0 OJI 1.25 
Affected dogs 0 0.50 1.33 
Q/R II 
Normal dogs 0.02 0.18 OJ3 
Carrier dogs 0.08 0.23 0.60 
Affected dogs OJI 0.62 1.00 
Q/R III 
Normal dogs 0.03 0.17 OJI 
Carrier dogs 0 0.18 0.57 
Affected dogs OJ2 0.61 1.00 
Q/R aVL 
Normal dogs 0 0 10.00 
Carrier dogs 0 0.50 3.50 
Affected dogs 0 0 0.25 
Q/R aVF 
Normal dogs 0.05 0.19 OJ2 
Carrier dogs 0.02 0.17 0.54 
Affected dogs OJ2 0.63 1.00 
Q/R CV 6LL (V 2) 
Normal dogs 0 0 0 
Carrier dogs 0 0.08 0.14 
Affected dogs 0 0.14 0.43 
Q/R CV6LU (V4 ) 
Normal dogs 0 0.01 0.13 
Carrier dogs 0 0.14 0.28 
Affected dogs 0.09 OJ3 1.75 
RlS CVsRL (VI) 
Normal dogs 0.50 1.21 10.00 
Carrier dogs OJO 1.11 3.20 
Affected dogs 0 1.26 1.87 
PR interval (ms) 
Normal dogs 70 115 140 
Carrier dogs 90 100 130 
Affected dogs 80 95 100 
Axis' 
Normal dogs 60 90 105 
Carrier dogs 30 60 90 
Affected dogs 45 75 90 
HR (beats/min) 
Normal dogs 80 100 160 
Carrier dogs 120 140 160 
Affected dogs 100 120 180 
'Examined in only four affected dogs. HR = heart rate. 
end-systole, left ventricular internal dimension at end-
diastole and end-systole, ventricular septal wall and left 
ventricular free wall excursion during systole, fractional 
shortening percent, and E point septal separation. Echocar-
diographic measurements were compared with published 
measurements for dogs for the same breed and similar 
weight (53-55). 
Radiography. Lateral and dorsoventral radiographic pro-
jections of the thorax were obtained in eight affected dogs. 
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Table 2. Statistical Comparisons of Electrocardiographic Variables Among Normal Dogs and Dogs Affected With or Carriers of 
Duchenne's Muscular Dystrophy 
Subanalysis 
Carriers With Lesions 
Normal (N) Versus Normal (N) Versus Carrier (C) Versus (C +) Versus Carriers 
Affected (A) Carrier (C) Affected (A) Without Lesions (C -) 
Variable Z p' Largert Z p Larger Z p Larger Z p Larger 
QIR I 0.2 0.855 0.6 0.577 0.9 0.366 1.3 0.201 
QIR II 3.5 <0.001 A 1.2 0.216 2.7 0.008 A 2.5 0.014 C+ 
QIR III 3.6 <0.001 A 0.1 0.885 2.8 0.006 A 1.6 0.121 
QIR aVL 0.6 0.523 0.9 0.332 1.9 0.063 0.2 0.855 
Q/R aVF 3.6 <0.001 A 0 0.984 3.0 0.003 A 2.1 0.036 C+ 
Q/R CV 6LL (V 2) 3.0 0.003 A 4.1 0 C 1.6 0.119 0.5 0.584 
QIR CV 6LU (V 4) 3.6 <0.001 A 2.5 0.013 C 1.7 0.097 0 1.0 
RlS CVsRL (VI) 0.4 0.671 0.9 0.375 0.3 0.802 0.5 0.648 
PR interval 2.7 0.007 N 2.0 0.043 1.3 0.191 1.4 0.171 
Axis 0.9 0.394 2.7 0.006 N 0.4 0.695 1.6 0.121 
Heart rate 1.6 0.121 3.0 0.003 C 1.1 0.291 0.1 0.927 
'Significant difference if p < 0.017 (correction for multiple comparisons) except for subanalysis (p < 0.05). tWhere a significant difference exists. the group 
of dogs with the larger value for that variable is identified. 
Statistics. Descriptive statistics were determined and 
comparisons among the control, affected and carrier dogs 
were made using the rank sum test with a Bonferroni 
adjustment for multiple comparisons. The statistical soft-
ware package Statistix® was used (56). 
Results 
Physical examination. One 6 year old affected dog had 
evidence of congestive heart failure with pulmonary edema 
and ascites. Two affected dogs and one carrier dog had a 
mild systolic murmur detected by auscultation over the 
mitral valve region. 
Electrocardiography (Tables 1 and 2). Compared with 
control dogs, affected dogs had an increased Q/R ratio 
because of deep and narrow Q waves in leads II , III, aVF, 
CV 6LL, and CV 6LU (Fig. I, Table 2). Carrier dogs had an 
increased Q/R ratio in leads CV 6LL and CV 6LU. Sub-
analysis to compare carrier dogs with and those without 
echocardiographic abnormalities revealed that carrier dogs 
with echocardiographic lesions have an increased Q/R ratio 
in leads II and aVF. Carrier dogs without such lesions were 
not significantly different from normaL Affected dogs had a 
greater increase in the Q/R ratio in leads II, III and a VF than 
did carrier dogs. The Q/R ratio increased with increasing age 
in three of six dogs followed up from age 6 months to > 2 
years (Fig. 2). The PR interval was shorter in affected dogs 
than control dogs. Carrier dogs had a more leftward mean 
electrical axis shift and higher heart rate compared with 
control dogs. Sinus arrest (pause) was present in two af-
fected dogs. Ventricular premature complexes and ventric-
ular tachycardia were present in four affected dogs and one 
carrier dog (Fig. 3). 
Echocardiography. Of the six affected dogs > 2 years of 
age, the left ventricular internal dimension at end-diastole 
was increased in four dogs and the left ventricular internal 
dimension at end-systole was increased in three (Table 3). 
Left atrial dilation was present in the one dog with conges-
Figure 1. Electrocardiogram recorded from a 6 year old (male) 
golden retriever with Duchenne's muscular dystrophy. The Q waves 
are narrow and deep in leads II, IlL and aVF, as well as CV 6LL and 
CV6LU (not shown). Leads were recorded at 25 mm/s , I cm/mV. 
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tive heart failure, Three dogs had a decreased fractional 
shortening percent and two had increased E point septal 
separation, decreased left ventricular wall excursion and 
ventricular septal excursion (Fig. 4). Two of these dogs had 
left ventricular and septal wall thinning. None of the carrier 
dogs had M-mode echocardiographic measurements outside 
of the normal reference ranges. 
Two-dimensional echocardiography revealed distinctive 
hyperechoic lesions in 12 of the 13 affected dogs and in 6 of 
the 11 carrier dogs. Of the 11 affected dogs followed up over 
time, the hyperechoic lesions were first detected in 6 dogs by 
6 months, in 2 dogs by 7 months, and in 1 dog each by 10,25 
and 29 months. The hyperechoic areas began in the infero-
posterior left ventricular free wall (Fig. 5A), and then 
progressed to include the papillary muscle and left ventric-
ular free wall toward the apex of the heart (Fig. 5B). 
Although the lesions were most obvious in the left ventric-
ular free wall and papillary muscles, the ventricular septum 
also had smaller hyperechoic areas. The intensity of the 
hyperechoic areas decreased when the dogs were > 2 years 
of age (Fig. 6). The carrier dogs had a similar distribution of 
hyperechoic areas but the size and intensity were less 
severe. One affected dog developed hypoechoic lesions 
around previously identified hyperechoic lesions (Fig. 7). 
The hyperechoic areas in these affected and carrier dogs 
corresponded to calcified myocardium and dense connective 
tissue and the hypoechoic areas corresponded to active 
myocardial necrosis. 
Radiography. Of the eight affected dogs in which tho-
racic radiographs were taken, all had a distinctly pointed 
apex (Fig. 8). Radiography failed to detect cardiomegaly 
even when documented by echocardiography. All dogs had 
dorsal deviation of the xiphoid of varying degrees and four 
had kyphosis of the cranial thoracic spine. Five had defor-
mity of the costal cartilages and one dog had cranial dis-
placement of the distal ends of the last three ribs. All dogs 
had a caudally located, flattened and irregularly contoured 
diaphragm. Two dogs had a hiatal hernia. None of these 
features were seen in the control dogs. 
Discussion 
The results of this study show that dogs affected with 
Duchenne's muscular dystrophy and dogs carrying the gene 
for Duchenne's muscular dystrophy have ECG abnormali-
ties similar to those of affected and carrier humans with 
Duchenne's muscular dystrophy. Distinctive echocardio-
graphic abnormalities were present in both affected and 
carrier dogs, establishing the importance of this model for 
the study of Duchenne's cardiomyopathy. 
Electrocardiography. Most commonly, the ECG of pa-
tients with Duchenne's muscular dystrophy is characterized 
by tall R waves in the right precordial lead V I' deep Q waves 
in the left precordial leads V 4' V 5' and V 6 and deep Q waves 
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Figure 2. Electrocardiograms (ECGs) recorded from a golden re-
triever (female) with Duchenne's muscular dystrophy. A, Normal 
ECG recorded at age 9 months. B, At age 35 months, deep and 
narrow Q waves are present. Leads were recorded at 25 mmls, 
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in leads I and aVL (10-12,17 ,24,25,27-33). An increased Q/R B 
ratio in leads I, II, and V 5 also is seen commonly and deep Q 
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waves in leads II, III, and a VF are detected in some patients. 
The Q waves do not resemble those seen in myocardial 
infarction because they are deep but not wide (28,32). A 
relatively reduced electromotive force in regions of the heart 
affected by myocardial dystrophy and exaggerated electro-
motive forces in preserved myocardium account for the deep 
Q waves (57). Dogs affected with muscular dystrophy also 
had deep Q waves and an increased Q/R ratio in leads II, Ill, 
a VF, V 2. and V 4' These dogs did not have tall R waves in 
lead VI' 
The distribution of myocardial dystrophy in the dog is 
similar to that in the human (50) and the alteration of 
electromotive forces presumably explains the development 
of deep Q waves. The depth of the Q wave and the Q/R ratio 
increased with age in these dogs. In humans, ECG changes 
have been reported by some investigators (10,24,58) to be 
independent of age or severity of disease; others (13,27) 
report a positive relation. Serial ECGs recorded in patients 
over time have been similar (17), although extensive studies 
have not been done. 
Human carriers can have the typical ECG changes 
associated with Duchenne's cardiomyopathy (32,59-61), 
with as many as 16% of young carriers and 6.5% of mature 
carriers having a tall R wave in lead V I and deep Q waves in 
the left precordial leads (59). The observation that a carrier 
displays the ECG pattern of Duchenne's cardiomyopathy 
suggests that lesions are present in a small portion of the 
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Figure 3. Electrocardiogram recorded from an 8 
month old golden retriever (male) with Duchenne's 
muscular dystrophy. Multiform ventricular ectopic 
beats are seen. Lead II was recorded at 25 mm/s, 
1.0 cm/mV. 
myocardium, or that the ECG is reflective not of the dystro-
phic lesion but of a genetically determined juvenile ECG 
(59). Carrier dogs had deep Q waves and an increased Q/R 
ratio in the left precordial leads V 2 and V 4, although the Q 
waves and the Q/R ratio in the limb leads were not signifi-
cantly different from those in control dogs. However, carrier 
dogs that had detectable echocardiographic and pathologic 
lesions had significantly deeper Q waves and an increased 
Q/R ratio in limb leads II and a VF. These findings support 
the assumption that the ECG pattern of Duchenne' s cardio-
myopathy is reflective of the dystrophic lesion. 
Conduction abnormalities have been reported with Du-
chenne's cardiomyopathy, although they are not a predom-
inant feature of the disease (17,25,37,62). A short PR interval 
has been documented by some (25,37,62,63) and it is con-
sidered to result from accelerated atrioventricular conduc-
tion (25,58,62). The PR interval during normal early child-
hood is short, with intracardiac intervals increasing as the 
conduction system matures (64,65). Dystrophic changes 
within the myocardium are proposed to retard this normal 
maturation. However, not all studies have confirmed a short 
PR interval (12,17,19). In this study, affected dogs did have 
a significantly shorter PR interval than that of control dogs. 
Ventricular tachycardia was identified in 4 (30%) of 13 
affected dogs and in 1 (9%) carrier dog. Patients with 
Duchenne's muscular dystrophy uncommonly have ventric-
ular ectopic activity (17,19,24,32,37); therefore, the fre-
Table 3. Echocardiographic Measurements in Six Dogs With Duchenne's Muscular Dystrophy 
Ventricular Septum LV Free Wall LV Internal E Point Ventricular LV Free 
(mm) (mm) Dimension (mm) Fractional Septal Septal Wall 
Weight Shortening Separation Excursion Excursion 
Dog Gender (kg) Diastole Systole Diastole Systole Diastole Systole (%) (mm) (mm) (mm) 
Male 23 6' 6' 8 10 56' 52' 7' 18' 0* 2' 
2 Female 19 5* 6* 5* 7' 60* 52* 13* 29" 4* 6* 
3 Male 18 8 12 7 12 38 24 37 0 5 10 
4 Male 18 7 10 8 12 42* 26 38 2 6 8 
5 Male 30 7 12 8 II 51' 38* 26* 4 7 8 
6 Female 24 7 II 8 12 36 25 31 I 5 8 
"Indicates values outside normal reference range for dogs of this size . LV = left ventricular. 
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Figure 4. M-mode echocardiograms recorded from a golden retriever 
(female) with Duchenne's muscular dystrophy. A, At age 6 months the 
fractional shortening is 29%. The left ventricular internal diameter mea-
sures 31 mm at end-diastole and 21 mm at end-systole. B, At age 37 
months the fractional shortening is 13%. The left ventricular diameter 
measures 60 mm at end-diastole and 52 mm at end-systole. LVe = left 
ventricular chamber; L VW = left ventricular free wall; S = ventricular 
septum. Paper speed 50 mmls, distance between markers 1 cm, 
quency of this arrhythmia appears to be greater in dogs with 
muscular dystrophy . Although sinus tachycardia is the most 
common abnormal rhythm seen in humans. a significant 
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Figure 5. Two-dimensional echocardiograms recorded from a 7 
month old female dog (Al and an 8 month old male dog with 
Duchenne's muscular dystrophy (B) . A modified parasternal long-
axis view of the left ventricle shows hyperechoic lesions clumped in 
the left ventricular free wall at the level of the chordae tendineae 
(arrow) in A, and in the papillary muscle and in the ventricular free 
wall (arrows) in B. 
elevation in the heart rate of affected dogs was not detected, 
whereas periods of marked sinus slowing and sinus arrest 
were found in some affected dogs. However, carrier dogs did 
have a significantly higher heart rate than that of control 
dogs. 
Echocardiography. The hyperechoic lesions seen in af-
fected and carrier dogs are distinctive. Most commonly, the 
hyperechoic lesions first appear when the dogs are approx-
imately 6 months old. The location of the hyperechoic 
lesions and their progression from the posterobasal left 
ventricular wall to the apex in these dogs corresponds to the 
progression of fibrosis in humans (19,20). Hyperechoic le-
sions are correlated with histologically recognizable areas of 
mineralization on pathologic examination. (50). The miner-
alization that follows myocyte necrosis may be particularly 
pronounced in the dog, allowing for echocardiographic rec-
ognition of this stage of myocardial dystrophy. As expected, 
the hyperechoic lesions seen in carrier dogs, although obvi-
ous, are not as severe as those seen in affected dogs. The fact 
that echocardiographic lesions are seen, and that those dogs 
with lesions also have ECG changes, clearly supports the 
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Figure 6. Two-dimensional echocardiogram of a 37 month old female 
golden retriever with Duchenne's muscular dystrophy. The left 
ventricular chamber is grossly dilated and contracts poorly. The 
papillary muscle shows mild hyperechoic lesions. 
premise that carrier dogs have some degree of myocardial 
dystrophy. Pathologic examination of the hearts of carrier 
dogs confirms this observation (unpublished observations, 
Cooper and Valentine, 1990). It is reasonable to assume that 
many human carriers have similar myocardial dystrophic 
changes. 
In examining the sizes of the cardiac structures of pa-
tients with Duchenne's cardiomyopathy, it is difficult to find 
a comparison group of equal age and weight (36). For this 
reason, as well as variation in the age and stage of disease at 
which patients have been studied, there are inconsistent 
reports (10,14,36,37,64) of chamber size and wall thickness. 
Normal reference ranges for immature golden retriever dogs 
Figure 7. Two-dimensional echocardiogram recorded from a 1 year 
old dog with Duchenne's muscular dystrophy. The dog developed 
severe myocardial necrosis around areas of the myocardium previ-
ously identified as having hyperechoic areas. The necrotic myocar-
dium (confirmed by postmortem examination) is seen as a hypo-
echoic region (arrows). 
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Figure 8. Lateral thoracic radiograph of a golden retriever with 
Duchenne's muscular dystrophy. The cardiac silhouette displays a 
distinctly pointed apex. Kyphosis of the cranial thoracic spine (left) 
and a hiatal hernia (right) are seen. 
are not available; therefore, only mature affected and carrier 
dogs were evaluated for cardiac size relative to body size. 
Dilation of the left ventricle was obvious in 67% of the 
affected dogs. Older dogs developed myocardial failure as 
evidenced by low percent fractional shortening. Similar 
deterioration has been confirmed in humans in the late stages 
of disease, although diastolic dysfunction can be detected 
earlier (l0, 11 ,23,34,39,42,43). Myocardial thinning was de-
tected in two dogs and it is believed that this represents 
replacement of myocardium with fibrous tissue (39). 
Radiographs failed to detect enlargement of the left 
ventricle in affected dogs, and this is similar to findings in 
humans (16,35). This finding illustrates the importance of 
echocardiographic and ECG examination in detecting Du-
chenne's cardiomyopathy. 
Conclusions. This study establishes the dog with muscu-
lar dystrophy as an animal model of Duchenne's cardiomy-
opathy and demonstrates that the heart in a carrier dog has 
features similar to, although less severe than, those of the 
heart in an affected dog. This finding has important implica-
tions for recognizing the likelihood of development of dys-
trophic changes in the heart of human carriers of Duchenne' s 
muscular dystrophy. 
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